Minor lesion mutational spectrum of the entire NF1 gene does not explain its high mutability but points to a functional domain upstream of the GAP- related domain

American Journal of Human Genetics

Volumn 66, Issue 3, 2000, Pages 790-818

  Fahsold, Raimund ^a   Hoffmeyer, Sven ^b   Mischung, Claudia ^c   Gille, Christoph ^c   Ehlers, Christian ^a   Kücükceylan, Nazan ^d   Abdel Nour, Maher ^c   Gewies, Andreas ^c   Peters, Hartmut ^c   Kaufmann, Dieter ^d   Buske, Annegret ^c   Tinschert, Sigrid ^c   Nürnberg, Peter ^c  

^a Gemeinschaftspraxis B Prager/AJ   (Germany)

^b Epidauros Biotechnologie AG   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d UNIVERSITY OF ULM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLCYTOSINE; ADENOSINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYTOSINE; GUANINE; THYMINE;

ARTICLE; CHROMOSOME ABERRATION; DEAMINATION; EXON; GENE CONVERSION; GENE DELETION; GENE MUTATION; HUMAN; NEUROFIBROMATOSIS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; STOP CODON;

EID: 0033924917     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1086/302809     Document Type: Article

References (100)

1. Abernathy CR, Rasmussen SA, Stalker HJ, Zori R, Driscoll DJ, Williams CA, Kousseff BG, et al (1997) NF1 mutation analysis using a combined heteroduplex/SSCP approach. Hum Mutat 9:548-554
2. Ahmadian MR, Stege P, Scheffzek K, Wittinghofer A (1997) Confirmation of the arginine-finger hypothesis for the GAP-stimulated GTP-hydrolysis reaction of Ras. Nat Struct Biol 4:686-689
3. Ainsworth PJ, Chakraborty PK, Weksberg R (1997) Example of somatic mosaicism in a series of de novo neurofibromatosis type 1 cases due to a maternally derived deletion. Hum Mutat 9:452-457
4. Andrews JD, Mancini DN, Singh SM, Rodenhiser DI (1996) Site and sequence specific DNA methylation in the neurofibromatosis (NF1) gene includes C5839T: the site of the recurrent substitution mutation in exon 31. Hum Mol Genet 5:503-507
5. Antonarakis SE, Kazazian HH, Tuddenham EG (1995) Molecular etiology of factor VIII deficiency in hemophilia A. Hum Mutat 5:1-22
6. Böddrich A, Griesser J, Horn D, Kaufmann D, Krone W, Nürnberg P (1995) Reduced neurofibromin content but normal GAP activity in a patient with neurofibromatosis type 1 caused by a five base pair duplication in exon 12b of the NF1 gene. Biochem Biophys Res Commun 214:895-904
7. Böddrich A, Robinson PN, Schülke M, Buske A, Tinschert S, Nürnberg P (1997) New evidence for a mutation hotspot in exon 37 of the NF1 gene. Hum Mutat 9:374-377
8. Cawthon RM, Weiss R, Xu G, Viskochil D, Culver M, Stevens J, Robertson M, et al (1990) A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 62:193-201
9. Clark SJ, Harrison J, Frommer M (1995) CpNpG methylation in mammalian cells. Nat Genet 10:20-27
10. Clementi M, Barbujani G, Turolla L, Tenconi R (1990) Neurofibromatosis-1: a maximum likelihood estimation of mutation rate. Hum Genet 84:116-118
11. Colman SD, Rasmussen SA, Ho VT, Abernathy CR, Wallace MR (1996) Somatic mosaicism in a patient with neurofibromatosis type 1. Am J Hum Genet 58:484-490
12. Colman SD, Williams CA, Wallace MR (1995) Benign neurofibromas in type 1 neurofibromatosis (NF1) show somatic deletions on NF1 gene. Nat Genet 11:90-92
13. Cooper DN, Krawczak M (1993) Human gene mutation. BIOS Scientific Publishers, Oxford
14. Cowell JK, Smith T, Bia B (1994) Frequent constitutional C to T mutations in CGA-arginine codons in the RB1 gene produce premature stop codons in patients with bilateral (hereditary) retinoblastoma, Eur J Hum Genet 2:281-290
15. Cummings LM, Glatefeller A, Marchuk DA (1993) NF1 related loci on chromosomes 2, 12, 14, 15, 20, 21, and 22: a potential role for gene conversion in the high spontaneous mutation rate of NF1? Am J Hum Genet Suppl 53:A672
16. Danglot G, Régnier V, Fauvet D, Vassal G, Kujas M, Bernheim A (1995) Neurofibromatosis 1 (NF1) mRNAs expressed in the central nervous system are differentially spliced in the 5′ part of the gene. Hum Mol Genet 4:915-920
17. Däschner K, Assum G, Eisenbarth I, Krone W, Hoffmeyer S, Wortmann S, Heymer B, et al (1997) Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene. Biochem Biophys Res Commun 234:346-350
18. Easton DF, Ponder MA, Huson SM, Ponder BA (1993) An analysis of variation in expression of neurofibromatosis (NF) type 1 (NF1): evidence for modifying genes. Am J Hum Genet 53:305-313
19. Eikenboom JC, Vink T, Briet E, Sixma JJ, Reitsma PH (1994) Multiple substitutions in the von Willebrand factor gene that mimic the pseudogene sequence. Proc Natl Acad Sci USA 91:2221-2224
20. Friedman JM, Birch PH (1997) Type 1 neurofibromatosis: a descriptive analysis of the disorder in 1,728 patients. Am J Med Genet 70:138-143
21. Gasparini P, Grifa A, Origone P, Coviello D, Antonacci R, Rocchi M (1993) Detection of a neurofibromatosis type I (NF1) homologous sequence by PCR: implications for the diagnosis and screening of genetic diseases. Mol Cell Probes 7:415-418
22. Gille C, Gille A, Booms P, Robinson PN, Nürnberg P (1998) Bipolar clamping improves the sensitivity of mutation detection by temperature gradient gel electrophoresis. Electrophoresis 19:1347-1350
23. Greenblatt MS, Bennett WP, Hollstein M, Harris CC (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 54: 4855-4878
24. Greger V, Debus N, Lohmann D, Hopping W, Passarge E, Horsthemke B (1994) Frequency and parental origin of hypermethylated RB1 alleles in retinoblastoma. Hum Genet 94:491-496
25. Gregory PE, Gutmann DH, Mitchell A, Park S, Boguski M, Jacks T, Wood DL, et al (1993) Neurofibromatosis type 1 gene product (neurofibromin) associates with microtubules. Somat Cell Mol Genet 19:265-274
26. Guha A, Lau N, Huvar I, Gutmann D, Provias J, Pawson T, Boss G (1996) Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene 12:507-513
27. Guo HF, The I, Hannan F, Bernards A, Zhong Y (1997) Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides. Science 276:795-798
28. Gutmann DH, Aylsworth A, Carey JC, Korf B, Marks J, Pyeritz RE, Rubenstein A, et al (1997) The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2. JAMA 278:51-57
29. Harder A, Macsuga C, Tinschert S, Nürnberg P, Peters H (1999) A novel 5-bp deletion in exon 30 of the neurofibromatosis type 1 (NF1) gene. Hum Mutat 13:259
30. Heim RA, Kam-Morgan LNW, Binnie CG, Corns DD, Cayouette MC, Farber RA, Aylsworth AS, et al (1995) Distribution of 13 truncating mutations in the neurofibromatosis 1 gene. Hum Mol Genet 4:975-981
31. Hoffmeyer S, Assum G (1994) An RsaI polymorphism in the transcribed region of the neurofibromatosis (NF1)-gene. Hum Genet 93:481-482
32. Hoffmeyer S, Assum G, Griesser J, Kaufmann D, Nürnberg P, Krone W (1995) On unequal allelic expression of the neurofibromin gene in neurofibromatosis type 1. Hum Mol Genet 4:1267-1272
33. Hoffmeyer S, Nürnberg P, Ritter H, Fahsold R, Leistner W, Kaufmann D, Krone W (1998) Nearby stop codons in exons of the neurofibromatosis type 1 gene are disparate splice effectors. Am J Hum Genet 62:269-277
34. Horn D, Robinson PN, Böddrich A, Buske A, Tinschert S, Nürnberg P (1996) Three novel mutations of the NF1 gene detected by temperature gradient gel electrophoresis of exons 5 and 8. Electrophoresis 17:1559-1563
35. Huson SM, Compston DA, Clark P, Harper PS (1989) A genetic study of von Recklinghausen neurofibromarosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 26: 704-711
36. Huson SM, Hughes RAC (1994) The neurofibromatoses: a clinical and pathogenetic overview. Chapman & Hall, London
37. Izawa I, Tamaki N, Saya H (1996) Phosphorylation of neurofibromatosis type 1 gene product (neurofibromin) by cAMP-dependent protein kinase. FEBS Lett 382:53-59
38. Jones AC, Shyamsundar MM, Thomas MW, Maynard J, Idziaszczyk S, Tomkins S, Sampson JR, et al (1999) Comprehensive mutation analysis of TSC1 and TSC2 - and phenotypic correlations in 150 families with tuberous sclerosis. Am J Hum Genet 64:1305-1315
39. Kehrer-Sawatzki H, Schwickardt T, Assum G, Rocchi M, Krone W (1997) A third neurofibromatosis type 1 (NF1) pseudogene at chromosome 15q11.2. Hum Genet 100: 595-600
40. Kim MR, Tamanoi F (1998) Neurofibromatosis 1 GTPase activating protein-related domain and its functional significance. In: Upadhyaya M, Cooper DN (eds) Neurofibromatosis type 1: from genotype to phenotype. BIOS Scientific Publishers, Oxford, pp 89-112
41. Klose A, Ahmadian MR, Schülke M, Scheffzek K, Hoffmeyer S, Gewies A, Schmitz F, et al (1998a) Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1 (NF1). Hum Mol Genet 7:1261-1268
42. Klose A, Nürnberg P, Tinschert S, Peters H (1998b) Recurrence of the neurofibromatosis type 1 (NF1) mutation R1276X probably due to interchromosomal gene conversion. Hum Mutat 12:291
43. Klose A, Peters H, Hoffmeyer S, Buske A, Lüder A, Hess D, Lehmann R, et al (1999) Two independent mutations in a family with neurofibromatosis type 1 (NF1). Am J Med Genet 83:6-12
44. Klose A, Robinson PN, Gewies A, Kluwe L, Kaufmann D, Buske A, Tinschert S, et al (1998c) Two novel mutations in exons 19a and 20 and a BsaBI [correction of BsaI] polymorphism in a newly characterized intron of the neurofibromatosis type 1 gene. Hum Genet 102:367-371
45. Korf BR (1998) The NF1 genetic analysis consortium. In: Upadhyaya M, Cooper DN (eds) Neurofibromatosis type 1: from genotype to phenotype. BIOS Scientific Publishers, Oxford, pp 57-63
46. Krawczak M, Reiss J, Cooper DN (1992) The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: causes and consequences. Hum Genet 90:41-54
47. Krkljus S, Abernathy CR, Johnson JS, Williams CA, Driscoll DJ, Zori R, Stalker HJ, et al (1998) Analysis of CpG C-to-T mutations in neurofibromatosis type 1. Hum Mutat 11: 411
48. Lázaro C, Kruyer H, Gaona A, Estivill X (1995) Screening for the neurofibromatosis type 1 recurrent mutation R1947X. Med Genetik 7:272 (Abstract)
49. Legius E, Marchuk DA, Collins FS, Glover TW (1993) Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 3:122-126
50. Legius E, Marchuk DA, Hall BK, Andersen LB, Wallace MR, Collins FS, Glover TW (1992) NF1-related locus on chromosome 15. Genomics 13:1316-1318
51. Lerman LS, Silverstein K (1987) Computational simulation of DNA melting and its application to denaturing gradient gel electrophoresis. Methods Enzymol 155:482-501
52. Li Y, Bollag G, Clark R, Stevens J, Conroy L, Fults D, Ward K, et al (1992) Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell 69:275-281
53. Li Y, O'Connell P, Huntsman-Breidenbach H, Cawthon R, Stevens J, Xu G, Neil S, et al (1995) Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 25:9-18
54. Lohmann DR, Brandt B, Höpping W, Passarge E, Horsthemke B (1996) The spectrum of RB1 germ-line mutations in hereditary retinoblastoma. Am J Hum Genet 58:940-949
55. Lohmann DR, Gerick M, Brandt B, Oelschläger U, Lorenz B, Passarge E, Horsthemke B (1997) Constitutional RR1-gene mutations in patients with isolated unilateral retinoblastoma. Am J Hum Genet 61:282-294
56. Marchuk DA, Saulino AM, Tavakkol R, Swaroop M, Wallace MR, Andersen LB, Mitchell AL, et al (1991) cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 11:931-940
57. Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, Conroy L, et al (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 63:843-849
58. Maru Y, Witte ON (1991) The BCR gene encodes a novel serine/threonine kinase activity within a single exon. Cell 67:459-468
59. Maynard J, Krawczak M, Upadhyaya M (1997) Characterization and significance of nine novel mutations in exon 16 of the neurofibromatosis type 1 (NF1) gene. Hum Genet 99: 674-676
60. Messiaen L, Callens T, De Paepe A, Craen M, Mortier G (1997) Characterisation of two different nonsense mutations, C6792A and C6792G, causing skipping of exon 37 in the NF1 gene. Hum Genet 101:75-80
61. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, et al (1994) A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266:66-71
62. Naylor J, Brinke A, Hassock S, Green PM, Giannelli F (1993) Characteristic mRNA abnormality found in half the patients with severe haemophilia A is due to large DNA inversions. Hum Mol Genet 2:1773-1778
63. Neote K, Brown CA, Mahuran DJ, Gravel RA (1990) Translation initiation in the HEXB gene encoding the β-subunit of human β-hexosaminidase. J Biol Chem 265: 20799-20806
64. Osborn M, Upadhyaya M (1998) Mutation analysis in the promoter and coding region of the NF1 gene. Am J Hum Genet Suppl 63:A378
65. Patten JL, Johns DR, Valle D, Eil C, Gruppuso PA, Steele G, Smallwood PM, et al (1990) Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy. N Engl J Med 322:1412-1419
66. Peters H, Hess D, Fahsold R, Schülke M (1999a) A novel mutation L1425P in the GAP-region of the NF1 gene detected by temperature gradient gel electrophoresis (TGGE). Hum Mutat 13:337
67. Peters H, Lüder A, Harder A, Schuelke M, Tinschert S (1999b) Mutation screening of neurofibromatosis type 1 (NF1) exons 28 and 29 with single strand conformation polymorphism (SSCP): five novel mutations, one recurrent transition and two polymorphisms in a panel of 118 unrelated NF1 patients. Hum Mutat 13:258
68. Purandare SM, Huntsman-Breidenbach H, Li Y, Lin Zhu X, Sawada S, Neil SM, Brothman A, et al (1995) Identification of neurofibromatosis 1 (NF1) homologous loci by direct sequencing, fluorescence in situ hybridization, and PCR amplification of somatic cell hybrids. Genomics 30:476-485
69. Purandare SM, Lanyon WG, Connor JM (1994) Characterisation of inherited and sporadic mutations in neurofibromatosis type-1. Hum Mol Genet 3:1109-1115
70. Pyeritz RE (1996) Disorders of fibrillins and microfibrillogenesis: Marfan syndrome and other disorders of fibrillin. In: Rimoin DL, Connor JM, Pyeritz RE (eds) Emery and Rimoin's principles and practice of medical genetics, 3rd ed. Churchill Livingstone, New York, pp 1027-1066
71. Rasmussen SA, Colman SD, Ho VT, Abernathy CR, Arn PH, Weiss L, Schwartz C, et al (1998) Constitutional and mosaic large NF1 gene deletions in neurofibromatosis type 1. J Med Genet 35:468-471
72. Régnier V, Meddeb M, Lecointre G, Richard F, Duverger A, Nguyen VC, Dutrillaux B, et al (1997) Emergence and scattering of multiple neurofibromatosis (NF1)-related sequences during hominoid evolution suggests a process of pericentromeric interchromosomal transposition. Hum Mol Genet 6:9-16
73. Riccardi VM (1992) Neurofibromatosis: phenotype, natural history, and pathogenesis, 2nd ed. John Hopkins University, Baltimore
74. Riccardi VM (1993) Genotype, malleotype, phenotype, and randomness: lessons from neurofibromatosis-1 (NF1). Am J Hum Genet 53:301-304
75. Riesner D, Steger G, Zimmat R, Owens RA, Wagenhöfer M, Hillen W, Vollbach S, et al (1989) Temperature-gradient gel electrophoresis of nucleic acids: analysis of conformational transitions, sequence variations, and protein-nucleic acid interactions. Electrophoresis 10:377-389
76. Robinson PN, Böddrich A, Peters H, Tinschert S, Buske A, Kaufmann D, Nürnberg P (1995) Two recurrent nonsense mutations and a 4 bp deletion in a quasi-symmetric element in exon 37 of the NF1 gene. Hum Genet 96:95-98
77. Robinson PN, Buske A, Neumann R, Tinschert S, Nürnberg P (1996) Recurrent 2-bp deletion in exon 10c of the NF1 gene in two cases of von Recklinghausen neurofibromatosis. Hum Mutat 7:85-88
78. Rodenhiser DI, Coulter-Mackie MB, Singh SM (1993) Evidence of DNA methylation in the neurofibromatosis type 1 (NF1) gene region of 17q11.2. Hum Mol Genet 2:439-444
79. Rodenhiser D, Mancini DN, Singh SM, Archer TK (1998) Site specific DNA methylation in the neurofibromatosis (NF1) promoter interferes with binding of CREB and SP1 transcription factors. Am J Hum Genet Suppl 63:A190
80. Sakai T, Toguchida J, Ohtani N, Yandell DW, Rapaport JM, Dryja TP (1991) Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 48: 880-888
81. Sandoval N, Platzer M, Rosenthal A, Dork T, Bendix R, Skawran B, Stuhrmann M, et al (1999) Characterization of ATM gene mutations in 66 ataxia telangiectasia families. Hum Mol Genet 8:69-79
82. Scheffzek K, Ahmadian MR, Wiesmuller L, Kabsch W, Stege P, Schmitz F, Wittinghofer A (1998) Structural analysis of the GAP-related domain from neurofibromin and its implications. EMBO J 17:4313-4327
83. Sergeyev AS (1975) On the mutation rate of neurofibromatosis. Humangenetik 28:129-138
84. Serra E, Puig S, Otero D, Gaona A, Kruyer H, Ars E, Estivill X, Lazaro C (1997) Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am J Hum Genet 61:512-519
85. Shannon KM, O'Connell P, Martin GA, Paderanga D, Oison K, Dinndorf P, McCormick F (1994) Loss of normal NF1 allele from the bone marrow of children with type 1 neurofibromatosis and malignant myeloid disorders. N Engl J Med 330:597-601
86. Suzuki T, Ishioka C, Kato S, Mitachi Y, Shimodaira H, Sakayori M, Shimada A, et al (1998) Detection of APC mutations by a yeast-based protein truncation test (YPTT). Genes Chromosomes Cancer 21:290-297
87. The I, Hannigan GE, Cowley GS, Reginald S, Zhong Y, Gusella JF, Hariharan IK, et al (1997) Rescue of a Drosophila Nf1 mutant phenotype by protein kinase A. Science 276: 791-794
88. Toliat MR, Erdogan F, Gewies A, Fahsold R, Buske A, Tinschert S, Nürnberg P (1999) Analysis of the NF1 gene by temperature gradient gel electrophoresis (TGGE) reveals a high incidence of mutations in exon 4b. Electrophoresis 21: 541-544
89. Tonsgard JH, Yelavarthi KK, Cushner S, Short MP, Lindgren V (1997) Do NF1 gene deletions result in a characteristic phenotype? Am J Med Genet 73:80-86
90. Upadhyaya M, Cooper DN (1998) The mutational spectrum in neurofibromatosis 1 and its underlying mechanisms. In: Upadhyaya M, Cooper DN (eds) Neurofibromatosis type 1: from genotype to phenotype. BIOS Scientific Publishers, Oxford, pp 65-88
91. Upadhyaya M, Osborn MJ, Maynard J, Kim MR, Tamanoi F, Cooper DN (1997) Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene. Hum Genet 99: 88-92
92. Valero MC, Velasco E, Moreno F, Hernandez-Chico C (1994) Characterization of four mutations in the neurofibromatosis type 1 gene by denaturing gradient gel electrophoresis (DGGE). Hum Mol Genet 3:639-641
93. Varon R, Vissinga C, Platzer M, Cerosaletti KM, Chrzanowska KH, Saar K, Beckmann G, et al (1998) Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell 93:467-476
94. Vogel F, Motulsky AG (1997) Human genetics: problems and approaches, 3rd ed. Springer-Verlag, Berlin
95. Wartell RM, Hosseini SH, Moran CP (1990) Detecting base pair substitutions in DNA fragments by temperature-gradient gel electrophoresis. Nucleic Acids Res 18:2699-2705
96. White R, O'Connell P (1991) Identification and characterization of the gene for neurofibromatosis type 1. Curr Opin Genet Dev 1:15-19
97. Wu B-L, Boles RG, Yaari H, Weremowicz S, Schneider GH, Korf BR (1997) Somatic mosaicism for deletion of the entire NF1 gene identified by FISH. Hum Genet 99:209-213
98. Wu J, Dent P, Jelinek T, Wolfman A, Weber MJ, Sturgill TW (1993) Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262:1065-1069
99. Wu R, López-Correa C, Rutkowski JL, Baumbach LL, Glover TW, Legius E (1999) Germline mutations in NF1 patients with malignancies. Genes Chromosomes Cancer 26:376-380
100. Xu G, O'Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, Dunn D, et al (1990) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 62:599-608